Zhongchao Operating Margin 2019-2024 | ZCMD
Current and historical operating margin for Zhongchao (ZCMD) over the last 10 years. The current operating profit margin for Zhongchao as of December 31, 2024 is 0.00%.
| Zhongchao Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.026B | $0.016B |
| Zhongchao Inc. is a provider of healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform. Zhongchao Inc. is headquartered in Beijing, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.602B | 59.29 |
| Tempus AI (TEM) | United States | $13.186B | 0.00 |
| Doximity (DOCS) | United States | $12.437B | 55.33 |
| Hims & Hers Health (HIMS) | United States | $9.717B | 79.61 |
| IRhythm Technologies (IRTC) | United States | $5.323B | 0.00 |
| Hinge Health (HNGE) | United States | $4.319B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.748B | 40.40 |
| Privia Health (PRVA) | United States | $2.626B | 194.54 |
| Heartflow (HTFL) | $2.422B | 0.00 | |
| Phreesia (PHR) | United States | $1.808B | 0.00 |
| Enovis (ENOV) | United States | $1.771B | 9.36 |
| 10x Genomics (TXG) | United States | $1.752B | 0.00 |
| Omnicell (OMCL) | United States | $1.520B | 29.28 |
| Schrodinger (SDGR) | United States | $1.438B | 0.00 |
| Azenta (AZTA) | United States | $1.410B | 61.52 |
| Clover Health Investments (CLOV) | United States | $1.356B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.140B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.570B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.474B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 132.75 |
| Butterfly Network (BFLY) | United States | $0.390B | 0.00 |
| Carlsmed (CARL) | United States | $0.380B | 0.00 |
| TruBridge (TBRG) | United States | $0.298B | 52.29 |
| Outset Medical (OM) | United States | $0.244B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.235B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.220B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.194B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 6.12 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| Pulmonx (LUNG) | United States | $0.068B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| PROFUSA (PFSA) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |